The high-dose flu vaccine is specifically approved for adults 65 and older. The CDC’s Advisory Committee on Immunization Practices (ACIP) preferentially recommends it as one of three enhanced flu vaccines for this age group, meaning it’s a better choice than a standard-dose shot when available.
Why Adults 65 and Older Need a Stronger Vaccine
As you age, your immune system produces a weaker response to vaccination. A standard flu shot still offers protection, but older adults tend to build fewer antibodies from the same dose that works well for younger people. The high-dose vaccine, sold as Fluzone High-Dose, compensates for this by packing 60 micrograms of active ingredient per flu strain, compared to the 15 micrograms in a standard shot. That’s four times the antigen, which pushes the aging immune system to mount a stronger defense.
The payoff is meaningful. In a study of Italian adults 60 and older, the high-dose vaccine was about 29% more effective than the standard dose at preventing lab-confirmed flu. Among those 80 and older, the gap widened: the high-dose version was 54% more effective. For the oldest adults, whose immune systems have declined the most, the extra antigen makes the biggest difference.
Three Preferred Options for People 65 and Older
The high-dose vaccine isn’t the only enhanced option. ACIP gives equal preferential status to three flu vaccines for adults 65 and older:
- Fluzone High-Dose: Uses four times the standard antigen to stimulate a bigger immune response. Egg-based.
- Fluad (adjuvanted vaccine): Contains a standard dose of antigen but adds an ingredient called an adjuvant, an oil-in-water compound that amplifies the immune response. Also egg-based.
- Flublok (recombinant vaccine): Made without eggs using recombinant technology, which can be a better match for circulating flu strains. A good option if you have a severe egg allergy.
All three are considered superior to a standard flu shot for this age group. There’s no strong evidence yet that one of the three outperforms the others, so the choice often comes down to what your pharmacy or doctor’s office has in stock. If none of these three are available when you show up for your shot, getting any age-appropriate flu vaccine is better than skipping it or waiting.
What About Adults Under 65?
The high-dose vaccine is only FDA-approved for adults 65 and older. There is no official recommendation to use it in younger adults, even those with chronic conditions like heart disease, diabetes, or weakened immune systems. That said, some healthcare providers have given it off-label to younger patients with serious health conditions. An analysis of U.S. vaccination records found over 36,000 doses administered to people under 65, and those recipients were more likely to have immune-compromising conditions, heart disease, chronic lung disease, or diabetes compared to younger adults who got the standard shot.
Still, no clinical guidelines support this practice. If you’re under 65 and have a condition that puts you at higher risk for flu complications, you should get the standard-dose flu vaccine recommended for your age group. The enhanced vaccines are reserved for 65 and older based on the available evidence.
Side Effects Compared to Standard Flu Shots
Because the high-dose vaccine delivers more antigen, it tends to cause slightly more side effects than a standard shot. In clinical studies, the most common reactions were pain and redness at the injection site, headache, muscle aches, and a general feeling of being unwell. These were mostly mild and resolved quickly. The trade-off is straightforward: a bit more soreness for meaningfully better protection.
Best Time to Get Vaccinated
For most adults 65 and older, September and October are the ideal months. The goal is to be vaccinated by the end of October, before flu activity typically peaks. Getting vaccinated too early, in July or August, is not recommended for older adults because protection can wane over the following months. Since aging immune systems may not hold onto vaccine-generated antibodies as long, timing matters more for this group than for younger people.
For the 2025-2026 season, all flu vaccines, including the high-dose version, are trivalent, meaning they protect against three flu strains: two influenza A viruses (H1N1 and H3N2) and one influenza B virus. This is a shift from the quadrivalent (four-strain) vaccines used in recent years, reflecting changes in which flu viruses are circulating globally.